Le Lézard
Classified in: Science and technology

Global Oncology Information Systems (Software, Professional Services) Market Size, Share & Trends Analysis Report 2022-2030 - ResearchAndMarkets.com

The "Oncology Information Systems Market Size, Share & Trends Analysis Report by Products & Services (Software, Professional Services), by Application (Medical Oncology, Surgical Oncology), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global oncology information systems market size is expected to reach USD 5.5 billion by 2030, registering a CAGR of 7.8%

Increasing prevalence of cancer around the globe and rising investment in product development about cancer research undertaken by key players are key driving factors for the growth of the market.

According to the estimates published by GLOBOCAN in 2020, 19.3 million new cancer cases were diagnosed and 10.0 million cancer-related mortalities were recorded. Cancer-causing infections like HPV and Hepatitis cause approximately 30% of cases in low-middle-income nations. The growing cancer burden is expected to boost the demand for advanced cancer care & management therapies with accurate and efficient results, thereby aiding the market growth.

Increasing investments in the field of oncology by both governments as well as key players is one of the key factors for boosting the market growth. The U.S. government has allocated $194 million towards Cancer Moonshot and $50 million to Childhood Cancer Data Initiative for the year 2022.

Market players are collaborating to enhance product development and expand their business footprint. For instance, in 2020 Accuray Inc. collaborated with Brainlab, a German digital surgery company, to expand Accuray's CyberKnife platform treatment abilities for the neuro-radiosurgery sector. In 2020, ViewRay Inc. collaborated with VieCure, an AI informatics company, to develop solutions to enhance the adoption of personalized cancer care. These factors are expected to drive market growth.

Software in the product & services segment held the largest market share in 2021. The rising adoption of software systems for patient data management and data sharing across different healthcare facilities is primarily responsible for the momentous growth of the market.

The OIS software is aimed at better management practices as well as providing better treatment courses for optimal patient outcomes. An uptick in the trend for professional services or outsourcing of OIS software management, due to the lack of skilled professionals in the healthcare settings, is also helping the market growth. The medical oncology application segment held the largest market share in 2021. It is also estimated to be the fastest-growing segment from 2022 to 2030.

Innovations in immunotherapy, radiotherapy as well as targeted therapy for specific cancers have led the market growth. The surgical oncology segment is also expected to witness significant growth owing to technological advancements in the field of surgical interventions related to the treatment of various cancers.

North America was the largest regional market in 2021 owing to the presence of major players. The sophisticated healthcare system and high awareness of the importance of proper management of patient data have also led to regional market growth. Asia Pacific is projected to be the fastest-growing regional market due to rising expenditure on healthcare IT and overall healthcare facilities and supportive government initiatives.

Oncology Information Systems Market Report Highlights

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Global Oncology Information Systems Market Variables, Trends, & Scope

Chapter 4 Oncology Information Systems Market: Products & Services Estimates & Trend Analysis

Chapter 5 Oncology Information Systems Market: application, Estimates & Trend Analysis

Chapter 6 Oncology Information Systems Market: Regional Estimates & Trend Analysis, by Products and Services, and Application

Chapter 7 Competitive Analysis

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/s5ae0b

These press releases may also interest you

at 07:35
DTx Pharma, Inc. (DTx), a privately-held biotechnology company developing novel RNA-based therapeutics to treat the genetic drivers of disease, today announced the appointment of Peter Condon as Chief Business Officer. Mr. Condon will be key to the...

at 07:35
CyberSaint, the developer of the leading platform delivering cyber risk automation, announced the addition of the FAIR (Factor Analysis of Information Risk) model within the CyberStrong platform today, providing customers with the ability to...

at 07:35
Nextech AR Solutions Corp. ("Nextech" or the "Company") , a Metaverse Company and leading provider of augmented reality ("AR") experience technologies and services is pleased to announce the signing of multiple deals in the events industry by the...

at 07:35
The Real Brokerage Inc. ("Real" or the "Company") , an international, technology-powered real estate brokerage, today announced that The Pozek Group, based in Orlando, Florida, is joining its growing network of agents. The Pozek Group has a team of...

at 07:35
Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced the opening of a new facility designed to manufacture clinical and commercial supply...

at 07:33
Eliassen Group, a strategic consulting company, announced today the appointment of individuals to several crucial roles: Eleanore Doyle as President, Global Head of Life Sciences and Doug Nelson as Chief Financial Officer. The company has also...

News published on 27 may 2022 at 10:30 and distributed by: